FDA warning letter
Closeout letter
Issue date
4 Jun 2019
Issuing office
Division of Pharmaceutical Quality Operations IV
Posted date
11 Jun 2019
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs
Issue date
6 Jul 2021